SQSTM1 mutations--bridging Paget disease of bone and ALS/FTLD

Area of Science:

• Genetics
• Neuroscience
• Skeletal Biology

Background:

• Paget disease of bone (PDB) is a skeletal disorder with a strong genetic basis, often linked to SQSTM1 gene mutations.
• Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are neurodegenerative disorders.
• Recent findings indicate SQSTM1 mutations in a subset of ALS/FTLD patients, a connection not previously recognized alongside PDB.

Purpose of the Study:

• To explore the link between SQSTM1 mutations in PDB and ALS/FTLD.
• To investigate how PDB-associated SQSTM1 mutations influence cellular pathways relevant to neurodegeneration.
• To gain insights into ALS/FTLD disease mechanisms through the lens of PDB genetics.

Main Methods:

• Review of genetic studies identifying SQSTM1 mutations in PDB, ALS, and FTLD.
• Analysis of the functional impact of identified SQSTM1 mutations on p62 protein pathways.
• Correlation of mutation location within the p62 protein sequence with disease phenotypes.

Main Results:

• SQSTM1 mutations are a common genetic factor in PDB.
• Several SQSTM1 mutations are implicated in both PDB and ALS/FTLD, while others appear specific to ALS/FTLD.
• The p62 protein, encoded by SQSTM1, regulates critical cellular processes like NF-κB signaling and autophagy.

Conclusions:

• Understanding the impact of PDB-related SQSTM1 mutations on cellular pathways offers new perspectives on ALS/FTLD pathogenesis.
• The SQSTM1 gene and its encoded p62 protein represent a potential shared molecular link between skeletal and neurodegenerative disorders.
• Further research into these shared genetic underpinnings may reveal novel therapeutic targets for both PDB and ALS/FTLD.